Dendreon Corp fka DNDNQ

[gofishmarko]

>> Delay of pain onset is certainly a clinical benefit, and this was the main component of progression in the SPAC trial. <<

Unless my concern about the trial being largely unblinded is baseless , I'd worry about assigning much importance to a subjective measure like 'delay of pain onset' , which would be highly susceptible to a placebo effect , or an investigator bias effect , or both.